Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scandella

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
The natural history of the immune response to exogenous factor VIII in severe haemophilia AD Scandella, W Mondorf, J Klinge
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1994
Hereditary hemorrhagic disordersJ Batlle, D Scandella, G Savidge
Blood|April 21, 2001
Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia AG Rossi, J Sarkar, D Scandella
Molecular & General Genetics : MGG|January 1, 1980
Genetic, biochemical, and developmental studies of nystatin resistant mutants in Dictyostelium discoideumD Scandella, R Rooney, E R Katz
The Journal of Clinical Investigation|June 1, 1989
Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipidM Arai, D Scandella, L W Hoyer
Haematologica|February 24, 2001
Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapyD Scandella, H Reyes, M Felch, et al.
The Journal of Biological Chemistry|January 25, 1990
Identification of the binding site for activated protein C on the light chain of factors V and VIIIF J Walker, D Scandella, P J Fay
The Journal of Biological Chemistry|April 15, 1994
A role for the C2 domain of factor VIII in binding to von Willebrand factorE L Saenko, M Shima, K J Rajalakshmi, et al.
Blood|October 1, 1989
Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralizationD Scandella, M Mattingly, S de Graaf, et al.
The Journal of Biological Chemistry|November 1, 1996
Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibitionE L Saenko, M Shima, G E Gilbert, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
The natural history of the immune response to exogenous factor VIII in severe haemophilia AD Scandella, W Mondorf, J Klinge
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1994
Hereditary hemorrhagic disordersJ Batlle, D Scandella, G Savidge
Blood|April 21, 2001
Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia AG Rossi, J Sarkar, D Scandella
Molecular & General Genetics : MGG|January 1, 1980
Genetic, biochemical, and developmental studies of nystatin resistant mutants in Dictyostelium discoideumD Scandella, R Rooney, E R Katz
The Journal of Clinical Investigation|June 1, 1989
Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipidM Arai, D Scandella, L W Hoyer
Haematologica|February 24, 2001
Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapyD Scandella, H Reyes, M Felch, et al.
The Journal of Biological Chemistry|January 25, 1990
Identification of the binding site for activated protein C on the light chain of factors V and VIIIF J Walker, D Scandella, P J Fay
The Journal of Biological Chemistry|April 15, 1994
A role for the C2 domain of factor VIII in binding to von Willebrand factorE L Saenko, M Shima, K J Rajalakshmi, et al.
Blood|October 1, 1989
Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralizationD Scandella, M Mattingly, S de Graaf, et al.
The Journal of Biological Chemistry|November 1, 1996
Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibitionE L Saenko, M Shima, G E Gilbert, et al.
Pageof 5